Register entry
CHIESI FARMACEUTICI SPA
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 46
- Exclusivities
- 5
- Countries
- 0
Exclusivity
Patents and exclusivities
46| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8828444 | FILSUVEZbirch triterpenes | product | Jun 2027 |
| 7932268 | JUXTAPIDlomitapide mesylate | use | Aug 2027 |
| 11969471 | MYCAPSSAoctreotide acetate | product | Sept 2029 |
| 11986529 | MYCAPSSAoctreotide acetate | use | Sept 2029 |
| 8329198 | MYCAPSSAoctreotide acetate | product | Sept 2029 |
| 8535695 | MYCAPSSAoctreotide acetate | use | Sept 2029 |
| 9265812 | MYCAPSSAoctreotide acetate | product | Sept 2029 |
| 9566246 | MYCAPSSAoctreotide acetate | product | Sept 2029 |
| 9352041 | FILSUVEZbirch triterpenes | use | Nov 2030 |
| 9827214 | FILSUVEZbirch triterpenes | use | Nov 2030 |
| 10159645 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | product | Dec 2030 |
| 10806701 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | product | Dec 2030 |
| 11389401 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | product | Dec 2030 |
| 11590074 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | use | Dec 2030 |
| 12357568 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | product | Dec 2030 |
| 10617638 | TRIMBOWbeclomethasone dipropionate; formoterol fumarate; glycopyrrolate | product | Dec 2034 |
| 10238709 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 10695397 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 11052126 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 11338011 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 11510963 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 11857595 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 12246054 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 12251418 | MYCAPSSAoctreotide acetate | use | Feb 2036 |
| 11083733 | FILSUVEZbirch triterpenes | product | Jan 2039 |
| 11266660 | FILSUVEZbirch triterpenes | use | Jan 2039 |
| 12268695 | FILSUVEZbirch triterpenes | use | Jan 2039 |
| 11141457 | MYCAPSSAoctreotide acetate | use | Dec 2040 |
| 11890316 | MYCAPSSAoctreotide acetate | use | Dec 2040 |
| 12472172 | JUXTAPIDlomitapide mesylate | use | Jul 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| FILSUVEZBIRCH TRITERPENES | ODE-460 Orphan drug | Dec 2030 |
| JUXTAPIDLOMITAPIDE MESYLATE | NPP New patient population | Feb 2029 |
| JUXTAPIDLOMITAPIDE MESYLATE | NS New strength | Feb 2029 |
| MYCAPSSAOCTREOTIDE ACETATE | ODE-474 Orphan drug | Jun 2027 |
| TRIMBOWBECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | NP New product | May 2029 |
Enquiry
Common questions
- Is CHIESI FARMACEUTICI SPA FDA approved?
- CHIESI FARMACEUTICI SPA holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.